Search Results

Active, currently enrolling    Who can join   

OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Active, currently enrolling    Who can join   

Case-Control Study II of Genomic Markers in Menstrual Blood for Diagnosis of Uterine Disorders

Keywords: Obstetrics and Gynecology;Endometriosis; Uterine Disorders
Study Type: OBSERVATIONAL   |  Region: Colorado

---

Enrollment complete    Who can join   

A Phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in women with recurrent platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Enrollment on hold    Who can join   

A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Enrollment complete    Who can join   

Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer (e3)

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Enrollment complete    Who can join   

A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With = 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Enrollment complete    Who can join   

(NSABP B-42) A CLINICAL TRIAL TO DETERMINE THE EFFICACY OF FIVE YEARS OF LETROZOLE COMPARED TO PLACEBO IN PATIENTS COMPLETING FIVE YEARS OF HORMONAL THERAPY CONSISTING OF AN AROMATASE INHIBITOR (AI) OR TAMOXIFEN FOLLOWED BY AN AI IN PROLONGING DISEASE-FREE SURVIVAL IN POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE BREAST CANCER

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: Colorado

---

Enrollment complete    Who can join   

(E5103) A DOUBLE-BLIND PHASE III TRIAL OF DOXORUBICIN AND CYCLOPHOSPHAMIDE FOLLOWED BY PACLITAXEL WITH BEVACIZUMAB OR PLACEBO IN PATIENTS WITH LYMPH NODE POSITIVE AND HIGH RISK LYMPH NODE NEGATIVE BREAST CANCER

Keywords: Oncology (Adult);Allergy and Immunology;Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: Colorado

---

Active, currently enrolling    Who can join   

Improving Medication Adherence in Metastatic Breast Cancer using a CONnected Customized Treatment Platform (CONCURxP)

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: Colorado

---

Enrollment complete    Who can join   

A Phase III Study Comparing Single-Agent Olaparib or the Combination of Cediranib and Olaparib to Standard Platinum-Based Chemotherapy in Women with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: Colorado

---